News

Arabian Post on MSN5h
Breakthrough Antibiotic To Combat Deadly Superbug Advances
Swiss pharmaceutical firm Roche has advanced its antibiotic candidate, zosurabalpin, into Phase 3 clinical trials, representing a potential landma ...
Le Lézard18h
Samsung Bioepis Presents Long-Term Safety Data of EPYSQLItm (Eculizumab) in PNH at the European Hematology Association (EHA) Congress 2025
Samsung Bioepis Co., Ltd. ("Samsung Bioepis") today presented the long-term safety data of EPYSQLItm (eculizumab; SB12), a biosimilar to Soliris1, in paroxysmal nocturnal hemoglobinuria (PNH) at the ...
PipelineReview.com16h
Samsung Bioepis Presents Long-Term Safety Data of EPYSQLI™ (Eculizumab) in PNH at the European Hematology Association (EHA) Congress 2025
INCHEON, Korea I June 12, 2025 I Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) today presented the long-term safety data of EPYSQLI™ (eculizumab; SB12), a ...
Summit Therapeutics Inc.
Summit Therapeutics Inc. company and executive profile by Barron's. View the latest SMMT company infomation and executive bios.